Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21837752 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Multiple Ascending Dose Study of BMS-790052 in Hepatitis C Virus (HCV) Infected Subjects
Condition: Chronic Hepatitis C
Interventions: Drug: BMS-790052;   Drug: Placebo

Indicates status has not been verified in more than two years